Cozen O'Connor snaps up Kilpatrick Townsend duo
28-10-2020
Fed Circuit refuses Amgen unit appeal in win for Sanofi
15-10-2020
Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms
06-10-2020
Grand Warszawski / Shutterstock.com
Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Kilpatrick Townsend & Stockton, DLA Piper, life sciences, patent litigation, Hatch-Waxman, innovation, biotech
